Format

Send to

Choose Destination
Eur Heart J. 2013 Aug;34(31):2444-52. doi: 10.1093/eurheartj/eht142. Epub 2013 Apr 26.

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II.

Author information

1
Brigham and Women's Hospital and Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. jbeckman@partners.org

Abstract

In part II of this review, we describe the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet treatment. Specifically, evidence-based cardiovascular therapies are discussed through novel clinical insights on management of hyperglycaemia, hypertension, dyslipidaemia as well as platelet dysfunction. Recent trends in the incidence and outcomes of vascular disease in diabetes suggest that timely and effective implementation of therapies is making a favourable impact.

KEYWORDS:

Diabetes; Medical therapy; Vascular disease

PMID:
23625211
DOI:
10.1093/eurheartj/eht142
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for Zurich Open Access Repository and Archive
Loading ...
Support Center